Addressing continuous data for participants excluded from trial analysis: A guide for systematic reviewers

Journal of Clinical Epidemiology

Volumn 66, Issue 9, 2013, Pages 1014-1021.e1

  Ebrahim, Shanil ^a,b   Akl, Elie A ^a,c,d   Mustafa, Reem A ^a,e   Sun, Xin ^a,f   Walter, Stephen D ^a   Heels Ansdell, Diane ^a   Alonso Coello, Pablo ^g   Johnston, Bradley C ^a,h,i,j   Guyatt, Gordon H ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^f Department of Cardiovascular Surgery   (China)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

more..

Author keywords

Continuous outcomes; Lost to follow up; Meta analysis; Missing participant data; Risk of bias; Systematic reviews

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; FOLLOW UP; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; STANDARD DEVIATION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 84882885812     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.03.014     Document Type: Article

References (22)

1. E.A. Akl, M. Briel, J.J. You, X. Sun, B.C. Johnston, and J.W. Busse LOST to follow-up Information in Trials (LOST-IT): potential impact on estimated treatment effects BMJ 344 2012 e2809
2. Further issues in meta-analysis: intention to treat issues Available at http://www.cochrane-net.org/openlearning/html/mod14-4.htm. Accessed July 26, 2012.
3. E.A. Akl, B.C. Johnston, A. Alonso-Coello, I. Neumann, S. Ebrahim, and M. Briel Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers PLoS One 8 2013 e57132
4. F.J. Molnar, B. Hutton, and D. Fergusson Does analysis using "last observation carried forward" introduce bias in dementia research? CMAJ 179 8 2008 751 753
5. J.H. Ware Interpreting incomplete data in studies of diet and weight loss N Engl J Med 348 2003 2136 2137
6. D.B. Rubin Multiple imputation for nonresponse in surveys 1987 John Wiley & Sons, Inc. New York, NY
7. The Cochrane Collaboration Chapter 8: Risk of bias J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions (Version 5.1.0) 2011 Cochrane Collaboration Oxford, UK
8. R.H.H. Groenwold, R.T. Donders, K.C.B. Roes, F.E. Harrell Jr., and K.G.M. Moons Dealing with missing outcome data in randomized trials and observational studies Am J Epidemiol 175 2011 210 217
9. J.P.T. Higgins, I.R. White, and A.M. Wood Imputation methods for missing outcome data in meta-analysis of clinical trials Clin Trials 5 2008 225 239
10. S. Ebrahim, L. Montoya, W. Truong, S. Hsu, M. Kamal el Din, and A. Carrasco-Labra Effectiveness of cognitive behavioral therapy for depression in patients receiving disability benefits: a systematic review and individual patient meta-analysis PLoS One 7 2012 e50202
11. J.M. Mella, M.C. Perret, M. Manzotti, H.N. Catalano, and G.H. Guyatt Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review Arch Dermatol 146 2010 1141 1150
12. J. Higgins, S. Thompson, J. Deeks, and D. Altman Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice J Policy Health Serv Res Policy 7 1 2002 51 61
13. L.E. de Graaf, S.A.H. Gerhards, A. Arntz, H. Riper, J.F.M. Metsemakers, and S.M.A.A. Evers Clinical effectiveness of online computerised cognitive behavioural therapy without support for depression in primary care: randomised trial Br J Psychiatry 195 2009 73 80
14. S. Misri, P. Reebye, M. Corral, and L. Milis The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial J Clin Psychiatry 65 2004 1236 1241
15. A. Rahman, A. Malik, S. Sikandar, C. Roberts, and F. Creed Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial Lancet 372 2008 902 909
16. Finasteride Male Pattern Hair Loss Study Group Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia Eur J Dermatol 12 1 2002 38 49
17. M. Leavitt, D. Perez-Meza, N.A. Rao, M. Barusco, K.D. Kaufman, and C. Ziering Effects of finasteride (1 mg) on hair transplant Dermatol Surg 31 2005 1268 1276
18. J. Leyden, F. Dunlap, B. Miller, P. Winters, M. Lebwohl, and D. Hecker Finasteride in the treatment of men with frontal male pattern hair loss J Am Acad Dermatol 40 6 Pt 1 1999 930 937
19. E.A. Olsen, M. Hordinsky, D. Whiting, D. Stough, S. Hobbs, M.L. Ellis Dutasteride Alopecia Research Team The importance of dual 5-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride J Am Acad Dermatol 55 2006 1014 1023
20. J.L. Roberts, V. Fiedler, J. Imperato-McGinley, D. Whiting, E. Olsen, and J. Shupack Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss J Am Acad Dermatol 41 1999 555 563
21. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
22. The Cochrane Collaboration Chapter 12: Interpreting results and drawing conclusions J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions (Version 5.1.0) 2011 Cochrane Collaboration Oxford, UK